Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 40/gram
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Bosutinib |
CAS NO | 380843-75-4 |
MF | C26H29Cl2N5O3 |
MW | 530.45 |
EINECS NO | 700-455-1 |
Melting point | 116-120 ºC |
Boiling point | 649.7±55.0 °C(Predicted) |
Density | 1.36 |
Storage Conditions | Room temp |
Bosutinib is a potent protein kinase inhibitor that inhibits both the autophosphorylation of Src protein and the phosphorylation of Src and Ab1 substrates in various human tumor cells.
Bosutinib is a kinase inhibitor indicated for the treatment of adults with chronic, accelerated or blast phase pre-Ph+ treatment-resistant or intolerant chronic myeloid leukemia (CML).
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance